Alexander Hardy
Chief Executive Officer presso BIOMARIN PHARMACEUTICAL INC.
Patrimonio netto: 13 M $ in data 31/03/2024
Profilo
Alexander Hardy is currently the President, Chief Executive Officer & Director at BioMarin Pharmaceutical, Inc. He is also a Director at Pharmaceutical Research & Manufacturers of America and a Member of The Wall Street Journal CEO Council.
Previously, he was the Chief Executive Officer & Director at Genentech, Inc. Hardy received his undergraduate degree from the University of Cambridge and his MBA from the Stephen M.
Ross School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 15/03/2024 | 148 151 ( 0.08% ) | 13 M $ | 31/03/2024 |
Posizioni attive di Alexander Hardy
| Società | Posizione | Inizio |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Chief Executive Officer | 01/12/2023 |
| The Wall Street Journal CEO Council | Corporate Officer/Principal | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Director/Board Member | - |
Precedenti posizioni note di Alexander Hardy
| Società | Posizione | Fine |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Executive Officer | - |
Formazione di Alexander Hardy
| University of Cambridge | Undergraduate Degree |
| Stephen M. Ross School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
| The Wall Street Journal CEO Council |
- Borsa valori
- Insiders
- Alexander Hardy
